Theratechnologies (TSE:TH) has released an update.
Theratechnologies Inc., a biopharmaceutical company, has bolstered its Board of Directors by appointing Elina Tea, an accomplished finance executive with extensive experience in private and public financing and M&A. Elina Tea, currently the CFO at GLS North America, is set to bring her expertise in corporate strategy and investor relations to the company’s Audit Committee. This strategic move aligns with Theratechnologies’ ongoing focus on expanding its commercial business and pursuing new partnerships and products.
For further insights into TSE:TH stock, check out TipRanks’ Stock Analysis page.
